Portola Pharmaceuticals Inc. buy tamam
Start price
02.01.18
/
50%
€44.54
Target price
02.01.19
€63.14
Performance (%)
-60.47%
End price
02.01.19
€17.61
Summary
This prediction ended on 02.01.19 with a price of €17.61. Massive losses of -60.47% were the result for the BUY prediction by tamam. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Portola Pharmaceuticals Inc. | 0.012% | 0.012% | -32.057% | -67.867% |
| iShares Core DAX® | 1,01 % | 2,70 % | 4,36 % | 51,69 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % | 18,00 % | 67,99 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % | 40,91 % | 57,11 % |
| iShares S&P 500 | -2,72 % | -1,75 % | 16,97 % | 58,87 % |
Comments by tamam for this prediction
In the thread Portola Pharmaceuticals Inc. diskutieren
tamam stimmt der Buy-Einschätzung von klostergang zu
tamam stimmt am 02.01.2018 der Buy-Einschätzung von klostergang mit dem Kursziel 70$ zu.Überschrift: PORTOLA a potential takeover candidate
(Laufzeit überschritten)
Stopped prediction by tamam for Portola Pharmaceuticals Inc.
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.16
03.01.19
03.01.19
€21.49
06.07.20
06.07.20
-6.71%
06.07.20
06.07.20
